Abstract: The new world primate Aotus sp. has been recommended by the World Health Organization as a model for evaluation of malaria vaccine candidates, given its susceptibility to experimental infection with the bUllan malaria parasites Plasmodiumfalciparum and P. vivax. The present study examined the in vitro proliferative response of peripheral blood mononuclear cells (PBMCs) isolated from Aotus monkeys, utilizing a wide range of mitogens. Results presented herein demonstrate that the in vitro proliferative response of PBMCs from the Aotus sp. is quite variable from monkey to monkey for each of the mitogens assessed. PBMCs from fue Aotus monkey exhibited a delayed kinetic proliferative response and, particularly, a different sensitivity to proliferation in response to various concentrations of Phytohemagglutinin-P and favin lectins, the phorbol ester Phorbol myristate acetate and the calcium ionophore ionomycin. Altogether, OUT findings are consistent with the conclusion that the in vitro proliferative response of PBMCs from the Aotus differ in their activation requirements compared with PBlv1Cs from humans.
vaccine design (31, 33) . However, to date, only a few functional studies for assessing basic immunologic processes in these monkeys have been conducted.
The rapid development of a vigorous T -cell proliferative response to foreign antigens is an essential determinant of the immune system's capacity to respond to immunologic challenge (27) . It is generally accepted that certain events in the T -lymphocyte activation process can be mimicked in vitro under certain conditions by stimulation of T cells with different polyclonal mitogens thus facilitating the evaluation of immune function.
In the studies reported herein, we have utilized a series of such polyclonal mito gens in attempts to elucidate differences (if any) in the in vitro proliferative response of peripheral blood mononuclear cells (PBMCs) from Aotus monkeys. The polyclonal mitogens used included: phytohemagglutinin-P (PHA-P), a phytomitogen derived from Phaseolus vulgaris seeds, which activates T lymphocytes through the T -cell receptor (TCR)
Introduction
The new world primate Aotus sp.(the owl monkey) is susceptible to infection with the human malaria parasites Plasmodium falciparum and P.vivax (10, 11, 17) . Due to their wide range of susceptibility to several species and developmental stages of the malaria parasites (9) and because the overall characteristics of infections with Plasmodium in this primate are remarkably similar to those of human malaria infections (34) , these animals are considered to be an excellent mQdel for studies of potential anti-malarial chemotherapeutic agents and vaccine candidates. This is t!1e basis by which the Aotus monkeys have been ~ecommended by the World Health Organizatiqn as a suitable experimental model for studies of malaria infection (7, 17) .
Severallaboratories including ours have carried out extensive studies using these non-human primate species in an effort to support its use as an experimental malaria model (4, 6, 9, 12-14, 25, 28, 35, 40) and particularly fof rational malaria 31 Aotus nancymae for 24 hour. The supernatant was co11ected and precipitated by centrifuging at 10 000 g for 6 hour at 4°C with 50% ammonium su1fate (Merck). The pe11et was resuspended in disti11ed water, dia1yzed against a 1% NaC1 solution for 24 hour, 1yophi-1ized and stored at -20°C. The powder was rehydrated with distilled water and purified by affinity chromatography with Sephadex G-100 (Amersham Pharmacia, Uppsa1a, Sweden). Favin was e1uted with 5% glucose (Merck) in 1% NaC1, and protein concentration was eva1uated with the bicinchoninic acid method (BCA) (Pierce, Rockford, IL, USA). The positive fractions were dia1yzed against a 1% NaC1 solution and stored at -20°C. Favin concentration was determined by the BCA assay. When used, the favin crude extract was reconstituted in RPMI 1640 (Gibco, Grand Is1and, NY, USA). Mitogens and were used at the concentrations and dilutions indicated in the texto and the surface co-stimulatory receptor CD2; favin, a lectin extracted from Vicia lava seeds previously reported to be mitogenic in these primates; phorbol myristate acetate (PMA), a compound that directly activates protein kinase C (PKC) and generates an IL-2-dependent response and the calcium ionophore ionomycin, which increases intracellular cytoplasmic calcium concentration, synergyzing with the P~C activator (16, 18, 20, 29, 39) .
Results obtained demonstrate that PBMCs from Aotus show distinctive qualities in the lymphocyte proliferative response, namely an inherent variability, a delayed proliferative kinetics and particularly, a different proliferative pattern in response to PHA-P, PMA, ionomycin and the favin crude extracto Our findings are consistent with the conclusion that PBMCs from the Aotus sp. might differ with regards to T -lymphocyte surfaces and eventually have different T -cell activation requirements compared with humans. These results may provide some understanding of the features of the immune response of Aotus spp. following immunization with specific malaria anti8ens.
Isolation of PBMCs
Peripheral blood mononuclear cells were obtained by density gradient separation using Lymphoprep (Nycomed, Oslo, Norway) as previously described (15) . Mononuclear cells were suspended in complete culture media consisting of RPMI 1640 supplemented with 10% fetal bovine serum (Hyclone, Logan UT, USA), 100 U/mI penicillin, 100 !lg/mI streptomycin (ICN, Costa Mesa, CA, USA), 1 mg/ml Minimum essential medium eagle (MEM) vitamin solution (except for rivoflavin 0.1 mg/mI) (Gibco), and 10 mg/mI non-essential aminoacids (Gibco). Viability was assessed by Trypan-blue dye exclusion, and on1y samples with > 90% viability were further cultured.
Materials and methods

Study subjects
More than 90 young male adult Aotus nancymae monkeys, kept at FIDIC's primate colony in Leticia, Colombia, were used as blood donors. The monkeys were routinely monitored for sanitary and health conditions. Anim~s appeared to be healthy and found to be free of c°}llIn°n infections. Peripheral blood was obtained in peparinized tubes and analyzed by microscopy to assess microfilaremia and only negative samples were selected. AlI samples were processed within a 12-16-hour timeinterval, as during this period no decrease in cell viability was detected. Heal1hy adult human donors were used for compariso~.
Leukagglutination assay
To assess the agglutinating properties of PHA-P and the favin extract to be used in the lymphocyte proliferative assays, 2 x 105 cells/well were cultured in duplicate or triplicate in a final 200 Jll volume of complete medium in 96-well flat-bottomed microculture plates (Linbro, McLean, VA, USA). Plates were subsequently incubated in a 5% COz humidified environment at 37°C for 24 hours. Leukagglutination was seen by light microscopy after 24 hours of culture. Only positive stocks were further employed in the lymphocyte proliferation assays.
Mitogens and antibodies
Phytohemagglutinin-P was purchased from Difco Laboratories (Detroit, MI, USA); PMA and ionomycin were purchased from Sigma (St Louis, MO, USA). PHA-P, PMA and jionomycin stock solutions were made in distilled water and DMSO, respectively. Further dilutions w~re made in complete culture medium. DMSO coptrols were without effect. The favin crude extract was prepared in the laboratory according to Arango et al. (1977) . Brietly, fue v: lava seeds w~re crushed and suspended in 1 % NaCl (Merck, Daqnstadt, Germany)
Lymphocyte proliferation assay
Peripheral blood mononuclear cells (1-2 x 105 cellsl well) were cultured in a final volume of 200 J.ll complete medium in triplicate in 96-well flat-bottomed microculture plate$. Stimulation was induced by the different mitogens described above. The plates were incubated in a 5% CO2 humidified environment at 37°C for 72 hours. For kinetic studies, the cultures were incubated for 24, 48 and 72 hours. Cell proliferation was measured by 3H-thymidine (5 ¡.tCi/well, Amersham Pharmacia, Uppsala, Sweden) incorporation during the last 18 hours of culture following tHe incubation period: 54 hours fQr humans and 72 hours for Aotus. The cultures were harvested with a semiautomatic cell-harverster (Cambridge Tech, Watertown MA, USA) anta glass fiber filter strips (Cambridge Tech) and air-dried before being placed in vials with 3 mI scintillation cocktail for radioactivity determination. The appropriatb controls were included in triplicate to detect non-specific background counts. The stimulatio. index (SI) was defined as the ratio of mean 3H-ihymidine (counts per minute) incorporated in th~ presence of the mitogenic agent to that incorporaited in the absence of the mitogenic agent. A1l the data presented herein are representative of at l~ast four separate experiments using different PBMC preparations.
by Bonferroni's comparison test between human and Aotus values at different time points was performed. Unpaired two-tailed t-test analyses were performed for the data comparing values obtained from human and Aotus at the same time points to confirnl the significance of the differences found.
Results
Proliferative response to PHA-P and favin lectins
As phytomitogens induce activation and stimu1ate a rapid and po1yc10na1 b1astogenic response interacting with a 1arge number of surface glycoproteins on human T 1ymphocytes (24) , it was of interest to determine the features of the Aotus monkey 1ym-phocyte pro1iferative response to PHA-P. The 1ymphocyte proliferation assay was conducted as previous1y described, stimu1ating Aotus PBMCs with 1-10 J.lg/ml of PHA-P, a range of concentrations previous1y reported to be mitogenic in human PBMCs (data not shown). In Aotus, there was a striking heterogeneity in the pro1iferative response, ranging from 10w-to-moderate, to this lectin at 2 J.lg/ml (Fig. lA, left side) . Similar results were observed with PHA-P at 1, 5, and 10 J.lg/ml (data not shown). In efforts to determine whether this heterogeneity in proliferative response was unique to PHA-P, we decided to evaluate the proliferative Heterogeneity ofthe proliferative response in Aotus to PHA-P and Favin (A) PBMCs from five humans and 10 Aotus were isolated and incubated for 72 hours in RPMI 1640 medium in the presence of PHA-P 2 j.lg/ml or favin crude extract 100 j.lg/m1; (B) PBMCs from humans and Aotus were incubated in presence ofPHA-P 2 j.lg/ml for 24, 48 and 72 hours. In each assay at 18 hours prior to the termination of the incubation periods, 3H-thymidine was added and its incorporation measured. Each data point represents mean SI representative of at least five separate experiments. The means of SI are shown as horizontallines. Human data points in (B), represent the mean value with the error bars showing S.E.M (*P < 0.05 and ** P < 0.001). PBMCs from humans and Aotus were incubated for 90 hours in the presence of PHA-P 2 J.lg/ml (experiment 1). twenty-one days later, blood was obtained from the same individuals and the assay was performed again (experiment 2).
In each assay at 18 hours prior to the termination of the incubation periods, 3H-thymidine was added and its incorporation measured. Each data point rep~sents mean stimulation indices of triplicate determinations.1 Human data points represents mean value of different indi~duals with the error bars showing SEM (* P < 0.05).
Heterogeneity of the Aotus individual proliferative response
Lymphocyte proliferation assays with samples from the same individuals collected following a 21-day interval, and stimulated under identical conditions (Fig. 2) , showed striking difference in the magnitude of the response in 50% of the animals. PBMCs from two additional A. nigriceps monkeys produced the same results (SI = 5 and 7.5; and SI = 2.6 and 7.5, for the first and second experiments, respectively). Therefore, the variability described above is not the consequence of having high or low responder animals. These findings confirm the results documented ealier and suggest an inherent variability in the mitogenic response. This behavior was never observed with samples from human donors.
response to a different type of lectin extracted from v: lava seeds, previously reportecJ to be mitogenic in these primates (38) . The crude e;1¡:tract was used at concentrations ranging between ~5 and 1 00 ~g/m1, because previous titration experintents showed that lower and/or higher concentrations were not mitogenic (data not shown). There waslow-to-moderate lymphoproliferative and variable response to the favin crude extract at 100 ~g/m1 (Fig. lA, right  side) . Similar results were consistently observed with the favin crude extract at 25, 50, and 75 ~g/m1 (data not shown). It is to be noted that PBMCs from the Aotus always respond~d better to the favin crude extract than humaln PBMCs, and conversely human PBMCs alway~ responded to a greater extent when stimulated with PHA-P. Aotus PBMCs proliferative response to other mitogens T -cell activation (bypassing cell surface interactions) was algo assessed by incubation of PBMCs with ionomycin and PMA. As illustrated (Fig. 3A) , our results demonstrate that, similar to humans, in PBMCs from Aotus monkeys treatment with ionomycin in addition to PMA is quite synergistic, generating a vigorous proliferative response. The most synergistic concentrations in Aotus were 2 Jlg/ml ionomycin and 25 ng/ml PMA. In humans, the optimal PMA concentration was 25 ng/ml as in Aotus; but, regarding ionomycin, it seemed that an intermediate concentration (0.5 Jlg/ml) was optimal. Figure 3B shows the proliferative response of Proliferation kinetics
Early reports indicated a delayed proliferation kinetics in Cynomolgus monkey PBMCs (36) and hence we decided to evaluate whether the features of the response described above could be because of different kinetics in Aotus PBMCs compared with humans. PBMCs from humans and Aotus, respectively, were stimulated for various time intervals with pftA-p at 2 1lg/m1 and the lymphoproliferative response was evaluated. A limited cell proliferatidn was observed following a 24 hour incubation I in PBMCs cultures from both humans and ,Aotus (Fig. lB) . Aotus and human PBMCs in response to PMA alone, PMA plus ionomycin, and PHA-P as control. It should be noted that no response was induced by PMA at 50 ng/ml alone, a treatment that was associated with a marked decrease in cell viability (35-45%) suggesting that a proapoptotic process was likely taking place. Furthermore, the cell death process induced by PMA (50 ng/ml) was reversed by a high calcium influx and a vigorous proliferative response was documented (see Fig. 3B , ionomycin 2 ~g/ml + PMA 50 ng/ml). When compared with PHA-P, it is important to note that the strong response observed in Aotus PBMCs stimulated with optimal concentrations of PMA and ionomycin (25 ng/ml and 2 ~g/ml, respectively), was always higher than that induced by PHA-P. The response to ionomycin, as a single stimulus in Aotus PBMCs, was also evaluated (Fig. 3C) . The results observed extend the data presented in Fig. 3B and demonstrate that Aotus T cells might be stimulated to proliferate with ionomycin alone (2 ~g/ml) and hence in response solely to an increase in cytosolic calcium concentration. Conversely, these results were not observed in human PBMCs, suggesting that calcium influx, in the absence of co-stimulation, is sufficient for proliferation of Aotus primary T cells, or that the T -cell activation thresholds mediated by the calcium influxes are lower in Aotus than in humans. In this report, we have evaluated the proliferative response of peripheral blood lymphocytes from A. nancymae to a wide range of mito gens and have shown the differential features of the response in this monkey species compared with humans. The proliferative responses to PHA-P and the favin crude extract were particularly interesting. Our results demonstrated the moderate mitogenic activity of both lectins and the considerable variability present in the proliferative response amongst different Aotus sp. In this respect, a previous work showed moderate and delayed lymphocyte proliferation responses in Cynomolgus monkeys to the PHA-P and Con A lectins (36) .
In our experiments, Aotus PBMCs clearly displayed a delayed kinetic response and required a longer incubation period for optimal proliferation. To date, the reasons for such differences in kinetics are unknown. One possibility, because of the fact that delayed responses were observed with all mitogens assessed (which in fact mediate activation through different signaling pathways), Ionomycin ~g/ml Fig. 3 . Aotus proliferative response to PMA and ionomycin PBMCs from humans and AatU\' were incubated under fue same conditions described in Fig. 2 . Cells were stimulated with (A) PMA 25 ng/ml plus ionomycin at 0.1; 0.5 or 2.0 ¡Lg/ml; (8) either PHA-P 10 ¡Lg/rnl; ionomycin 2 ¡Lg/ml plus PMA at 25 or 50 ng/rnl; or PMA alone at 25 or 50 ng/ml (C) ionomycin alone at 0.1; 0.5 or 2.0 ¡Lg/rnl as indicated. Each point represents mean stimulation indices of trip1icate cultures. Human data are representative of at least four separate experiments using different PBMCs preparations.
is that longer stimulation perio~s are required in Aotus PBMCs as a result of ditTerences in cell surface molecules expression and/or ditTerent intracellular requirements for optimal T -cell activation. In this respect, it is known that PHA-P interacts with specific pentasaccharide complexes present in the TCR and CD2 molecules in human T cells (24, 29) . The naturalligands for this .lectin in Aotus T lymphocytes have not been described, to date. However, it has been described that Aotus T cells readily form rosettes with sheep red blood cells (6) , and recent phenotype analysis of cell surface molecules in PBMCs from owl monkeys revealed high density of CD2 molecule expression as defined by the OKTll anti-CD2 monoclonal antibody (8) .
Owing to the great similarities reported in surface molecules, between Aotus and humans, including the TCR (40) and the ubiquity of glycosylated proteins on the surface of T cells, one would expect a similar response to PHA-P in Aotus PBMCs compared with human PBMCs; however this does not seem to be fue case. Aotus PBMCs always responded to a lesser extent. It is conceivable that there is some degree of diversity in, the nature of the glycosylated molecules on the sUrface of Aotus T cells that could generate ditTerences in the recognition of the structures capable of inducing T -cell mitogenesis, reasoning that is further supported by the results obtained with the favin crude extract, as Aotus PBMCs always responded better to this lectin. However, to date the favin ligands have only' been characterized in their saccharide complex (2) , and therefore their specificity to other surface molecules inducing mitogenesis is ignored.
Our experiments, stimulating Aotus and human T lymphocytes with PMA and ionomycin are algo interesting. First, our results demonstrated that, as documented in humans (18, 23) , this type of stimulation is synergistic in Aotus monkey PBMCs at low to moderate PMA concentration and at moderate calcium concentration. Secondly, in both humans and Aotus PBMCs, the cell death process generated by PKC over activation was reversed by a strong intracellular calcium influx. However, the magnitude of the response to this calcium influx was much more vigorous in Aotus PBMCs. This could be explained by the relative importance of this calcium-dependent pathway in the activation process in Aotus T cells compared with humans. Finally, when Aotus T lymphocytes were activated by culturing with ionomycin and PMA (bypassing cell surface interactions) we found ditTerences in the maximal/optimal proliferative response between this monkey species and humans. The reasons for this observation are not known but could be because of differences in T -cell activation requirements.
This data takes on additional significance if we consider IL2 synthesis. Thus, IL2 mRNA and protein accumulation are the limiting factors for T -cell proliferation after exposure to PMA and ionomycin (22) . Ionomycin alone is not able to induce either transcription of IL2 and IL2R (19, 23) , or proliferation. We examined this issue and, as expected, humans were unresponsive to ionomycin, suggesting that optima1 human T -cell activation requires simultaneous PKC activation as has been confumed by others (21, 22, 39) . Surprisingly, Aotus T cells responded to a calcium influx in the abscence of other co-stimulatory signals (pKC activation) although to a minor extent than when simultaneous activation was performed. It is tempting to speculate that calcium signals might be sufficient to activate Aotus T cells and induce gene expression and cell proliferation, suggesting that calcium influx is rather more important for proliferation in Aotus than in human primary T cells.
Thus, very delicate extracellular and serum calcium regulation ought to be present in this primate to achieve optimal calcium-mediated activation and signaling. Interestingly, this hypothesis is in keeping with earlier findings that suggest a delicate calcium regulation system in this new world primate, expressing vitamin D receptors and a new type of intracellular vitamin D binding proteins in activated T cells (3) , and requiring high circulating levels of steroid hormones, including vitamin D, gonadal steroids, glucocorticoids and mineralocorticoids for optimal calcium homeostagis (1, 3, 5, 26) .
Finally, analysis of the T -cell proliferative response in the Aotus spp. demonstrated that, although the optimal culture conditions described earlier were systematically applied during subsequeni lymphocyte proliferation assays, considerable variability was found from animal to animal. Previous studies have revealed the normal variability of the proliferative response in other primates (30, 32, 37, 41) . We observed a persistent heterogeneity in the response amongst different individuals and particularly amongst different samples obtained from two separate bleedings (21 days interval) from the same donor. Therefore, this variability was not the consequence of a mixture of high and low responder animals. Indeed, this variability was algo noted by Dr Alberto Moreno (Emory University, Atlanta, USA) with regard to Con A induced proliferation, mixed lymphocyte reaction and cytokines production in vaccinated and non vaccinated animals (personnal communication).
As we wanted to develop an in vitro system for optimal and reproducible mitogenic-stimulation to assess proliferative response with a number of welldefined malaria-antigens, the results are then quite valuable as they demonstrate that Aotus show a qualitatively different proliferative response to PHA-P, PMA, ionomycin and the favin crude extract and, particularly, a delayed proliferative kinetics, an unusual sensitivity to calcium signals and an inherent variability from monkey to monkey. Our findings support the view that Aotus might eventualIy have different T -cell activation requirements compared with humans and, therefore, the data from this study should be taken into consideration when subsequent studies are to be undertaken utilizing this primateas a model for human malaria.
